Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced its ...
Roughly one billion people worldwide are estimated to live with obstructive sleep apnea, and a large share of them don't know it. For the ones who do get diagno ...
Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...
I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to the final call in our 2026 MedTech Innovation Spotlight Series. I'm pleased to be joined by Inspire Medical's management team ...
Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...
Presentation at SLEEP 2026 illustrates ability to convert non-responders into responders using personalized programming LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today ...
A single night of sleep testing may not be enough to diagnose sleep apnea, with new Flinders University research revealing ...
The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
A Spanish trial finds positional therapy improves positional sleep apnea, is better tolerated than CPAP, and maintains benefits in many patients after treatment ends.
Women Hit Harder By Sleep Apnea Than Men, Study Finds By Dennis Thompson HealthDay ReporterWEDNESDAY, June 10, 2026 (HealthDay News) — Women with sleep apnea tend to suffer from it more than men, even ...
A large urban health system study suggests that COVID-19 may leave a lasting impact on sleep-breathing, with a higher risk of new-onset OSA even among patients who were never hospitalized. Study: Risk ...
Becoming a new mother brings more than just joyful chaos it delivers a profound and persistent sleep shock. A new study reveals that first-time moms lose not just total sleep, but crucial ...